DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, today announces that it will be presenting brand-new data on ...
When the Precision Medicine Initiative was launched in 2015, it completely transformed patient care in oncology. Now, individual differences in genetics, environment and lifestyle, along with the ...
Next-generation sequencing (NGS) has been making tremendous strides in the research market and with Illumina’s recent launch of the HiSeq X Ten, we’ve essentially reached the $1,000 genome ...
A new research perspective was published in Oncotarget's Volume 13 on November 17, 2022, entitled, "Treasures from trash in cancer research." Cancer research has significantly improved in recent years ...
FT. MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, will present three studies at the European Society for Medical Oncology (ESMO) Congress ...
Collaboration integrates DNAnexus’ proven biomedical data analysis platform with Twist’s NGS Methylation Detection and Unique Molecular Identifier Adapter Systems The Twist NGS Methylation Detection ...
When carrying out conventional PCR workflows users have to specify how many amplification cycles they need according to input quantity and assay type. This rigid structure is particularly difficult ...
Today, Inocras, a leader in whole genome sequencing (WGS) and bioinformatics, announced MRDVision, its solution for minimal residual disease (MRD) detection, validated to CLIA standards. The assay, ...
Upon completion of an Illumina sequencing run, the data is automatically sent through a series of custom pipelines. FASTQ files are generated for all samples within a run and provided to the user in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback